How do you know if your QI intervention resulted in improvement? What are ways to analyze data to demonstrate the positive benefits of your QI initiative? Control charts are a fundamental tool used in QI to display data over time and allows teams to evaluate their interventions and demonstrate their impact on clinical processes and outcomes. Using interactive exercises and illustrative examples, participants will learn how to differentiate between various types of control charts, analyze them for special cause variation, and interpret their findings. Participants will also learn how to create control charts using QI Macros through instructor-led examples.
Note: Participants should have a basic understanding of run charts and data for improvement prior to attending this masterclass. You do not need a license to QI Macros to sign up.
- Review run charts and control charts
- Select an appropriate control chart based on the type of data being collected
- Interpret run and control charts to determine whether common or special cause variation exists
- Review additional advanced topics in SPC including freezing the baseline, subgrouping and how to approach common vs special cause variation in QI projects
- Create control charts using QI macros.
Date and time:
- Friday, August 18, 12-4 p.m. ET
- $400 – non-members
- $300 – CQUIPS+ members (25% discount!)
Dr. Genevieve Bouchard-Fortier is a gynecologic oncologist at University Health Network. She obtained her MD at McGill University. She completed a residency program and fellowship in Gynecologic Oncology in the Department of Obstetrics and Gynaecology at the University of Toronto. During this time, Dr. Bouchard-Fortier also obtained a Master of clinical epidemiology focusing on cancer screening and cancer prevention at the Harvard School of Public Health. More recently, she did a certificate in Patient Safety and Quality improvement with the Center for Quality Improvement and Patient Safety (CQUIPS) and did the CQUIPS Improvement Fellowship. Dr. Bouchard-Fortier research and clinical interests include management of gestational trophoblastic disease as well as development of quality metrics and quality initiatives to improve gynecologic oncology care.